- Home
- KALA vs XWEL Comparison
KALA vs XWEL Comparison
Compare KALA & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- XWEL
- Stock Information
- Founded
- KALA 2009
- XWEL 2006
- Country
- KALA United States
- XWEL United States
- Employees
- KALA N/A
- XWEL N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- KALA Health Care
- XWEL Consumer Discretionary
- Exchange
- KALA Nasdaq
- XWEL Nasdaq
- Market Cap
- KALA 5.1M
- XWEL 4.8M
- IPO Year
- KALA 2017
- XWEL N/A
- Fundamental
- Price
- KALA $0.89
- XWEL $0.76
- Analyst Decision
- KALA Buy
- XWEL
- Analyst Count
- KALA 3
- XWEL 0
- Target Price
- KALA $31.50
- XWEL N/A
- AVG Volume (30 Days)
- KALA 1.6M
- XWEL 102.0K
- Earning Date
- KALA 11-19-2025
- XWEL 11-14-2025
- Dividend Yield
- KALA N/A
- XWEL N/A
- EPS Growth
- KALA N/A
- XWEL N/A
- EPS
- KALA N/A
- XWEL N/A
- Revenue
- KALA N/A
- XWEL $29,523,000.00
- Revenue This Year
- KALA N/A
- XWEL N/A
- Revenue Next Year
- KALA N/A
- XWEL N/A
- P/E Ratio
- KALA N/A
- XWEL N/A
- Revenue Growth
- KALA N/A
- XWEL N/A
- 52 Week Low
- KALA $0.61
- XWEL $0.70
- 52 Week High
- KALA $20.60
- XWEL $2.00
- Technical
- Relative Strength Index (RSI)
- KALA 39.51
- XWEL 38.92
- Support Level
- KALA $0.61
- XWEL $0.72
- Resistance Level
- KALA $0.70
- XWEL $0.99
- Average True Range (ATR)
- KALA 0.09
- XWEL 0.06
- MACD
- KALA 0.25
- XWEL -0.01
- Stochastic Oscillator
- KALA 70.38
- XWEL 27.57
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.